Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration NCT02933489 ECOG-ACRIN Cancer Research Group
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI)
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI)
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo NCT02917629 National Cancer Institute (NCI)
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Real Acupressure Band, Placebo Acupressure Band NCT01346267 University of South Florida
Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer Acupuncture NCT01141231 M.D. Anderson Cancer Center
Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients In-depth Patient Interviews, Adaptation of IMCP for Chinese Immigrant Cancer Patients NCT02112188 Memorial Sloan Kettering Cancer Center
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI)
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and... Olanzapine, Chemotherapy (cisplatin or cyclophosphamide and doxorubicin), Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant), Placebo NCT02116530 Alliance for Clinical Trials in Oncology

Pages